Susquehanna International Group’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,403,000
| Closed | -$248M | – | 11464 |
|
|
2020
Q1 | $248M | Sell |
1,403,000
-299,100
| -18% | -$56.3M | 0.08% | 189 |
|
|
2019
Q4 | $325M | Sell |
1,702,100
-21,200
| -1% | -$3.82M | 0.09% | 172 |
|
|
2019
Q3 | $290M | Sell |
1,723,300
-663,600
| -28% | -$108M | 0.1% | 165 |
|
|
2019
Q2 | $400M | Buy |
2,386,900
+725,400
| +44% | +$100M | 0.15% | 107 |
|
|
2019
Q1 | $243M | Buy |
1,661,500
+116,500
| +8% | +$16.9M | 0.1% | 162 |
|
|
2018
Q4 | $207M | Sell |
1,545,000
-474,900
| -24% | -$77.9M | 0.08% | 200 |
|
|
2018
Q3 | $385M | Sell |
2,019,900
-545,800
| -21% | -$100M | 0.13% | 115 |
|
|
2018
Q2 | $428M | Sell |
2,565,700
-610,900
| -19% | -$98.1M | 0.15% | 101 |
|
|
2018
Q1 | $535M | Sell |
3,176,600
-623,300
| -16% | -$105M | 0.19% | 68 |
|
|
2017
Q4 | $622M | Buy |
3,799,900
+732,200
| +24% | +$131M | 0.22% | 60 |
|
|
2017
Q3 | $629M | Buy |
3,067,700
+1,128,500
| +58% | +$262M | 0.24% | 55 |
|
|
2017
Q2 | $471M | Sell |
1,939,200
-95,800
| -5% | -$22.5M | 0.21% | 76 |
|
|
2017
Q1 | $486M | Sell |
2,035,000
-528,900
| -21% | -$123M | 0.25% | 57 |
|
|
2016
Q4 | $538M | Sell |
2,563,900
-556,900
| -18% | -$115M | 0.27% | 52 |
|
|
2016
Q3 | $719M | Sell |
3,120,800
-981,700
| -24% | -$240M | 0.35% | 38 |
|
|
2016
Q2 | $948M | Buy |
4,102,500
+920,300
| +29% | +$212M | 0.51% | 27 |
|
|
2016
Q1 | $853M | Sell |
3,182,200
-135,300
| -4% | -$38.7M | 0.45% | 31 |
|
|
2015
Q4 | $1.04B | Buy |
3,317,500
+1,030,400
| +45% | +$307M | 0.48% | 31 |
|
|
2015
Q3 | $622M | Buy |
2,287,100
+787,600
| +53% | +$242M | 0.27% | 46 |
|
|
2015
Q2 | $455M | Sell |
1,499,500
-709,100
| -32% | -$211M | 0.19% | 66 |
|
|
2015
Q1 | $657M | Buy |
2,208,600
+265,200
| +14% | +$75.6M | 0.3% | 35 |
|
|
2014
Q4 | $500M | Buy |
1,943,400
+277,400
| +17% | +$69.3M | 0.2% | 76 |
|
|
2014
Q3 | $402M | Buy |
1,666,000
+874,700
| +111% | +$196M | 0.15% | 94 |
|
|
2014
Q2 | $176M | Buy |
791,300
+82,300
| +12% | +$17M | 0.08% | 210 |
|
|
2014
Q1 | $146M | Buy |
709,000
+284,200
| +67% | +$56.3M | 0.07% | 246 |
|
|
2013
Q4 | $71.4M | Buy |
424,800
+141,600
| +50% | +$22.1M | 0.03% | 491 |
|
|
2013
Q3 | $40.8M | Sell |
283,200
-68,900
| -20% | -$9.18M | 0.02% | 701 |
|
|
2013
Q2 | $44.4M | Buy |
+352,100
| New | +$39.9M | 0.03% | 622 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Susquehanna International Group's AGN Position: Q2 2020 in Review
Susquehanna International Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 324,281 shares — an estimated $57.4M sold.
Susquehanna International Group first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $392M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Susquehanna International Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Susquehanna International Group sold 324,281 Allergan plc shares in Q2 2020, an estimated $57.4M.
- Susquehanna International Group first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Susquehanna International Group's Allergan plc position peaked at $392M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.